These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 16815805)

  • 1. Connecting stuttering management and measurement: I. Core speech measures of clinical process and outcome.
    Shenker RC
    Int J Lang Commun Disord; 2006; 41(4):355-64. PubMed ID: 16815805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connecting stuttering management and measurement: V. Deduction and induction in the development of stuttering treatment outcome measures and stuttering treatments.
    Onslow M
    Int J Lang Commun Disord; 2006; 41(4):407-21. PubMed ID: 16815809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connecting stuttering measurement and management: II. Measures of cognition and affect.
    Susca M
    Int J Lang Commun Disord; 2006; 41(4):365-77. PubMed ID: 16815806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connecting stuttering management and measurement: IV. Predictors of outcome for a behavioural treatment for stuttering.
    Block S; Onslow M; Packman A; Dacakis G
    Int J Lang Commun Disord; 2006; 41(4):395-406. PubMed ID: 16815808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled non-inferiority trial of a telehealth treatment for chronic stuttering: the Camperdown Program.
    Carey B; O'Brian S; Onslow M; Block S; Jones M; Packman A
    Int J Lang Commun Disord; 2010; 45(1):108-20. PubMed ID: 19424889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How effective is therapy for childhood stuttering? Dissecting and reinterpreting the evidence in light of spontaneous recovery rates.
    Saltuklaroglu T; Kalinowski J
    Int J Lang Commun Disord; 2005; 40(3):359-74. PubMed ID: 16195194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Speech outcomes of a prolonged-speech treatment for stuttering.
    Onslow M; Costa L; Andrews C; Harrison E; Packman A
    J Speech Hear Res; 1996 Aug; 39(4):734-49. PubMed ID: 8844554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using syllable-timed speech to treat preschool children who stutter: a multiple baseline experiment.
    Trajkovski N; Andrews C; Onslow M; Packman A; O'Brian S; Menzies R
    J Fluency Disord; 2009 Mar; 34(1):1-10. PubMed ID: 19500711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial of the D.E.L.P.H.I.N. speech treatment for children and adolescents who stutter.
    Keilmann A; Neumann K; Zöller D; Freude C
    Logoped Phoniatr Vocol; 2018 Dec; 43(4):155-168. PubMed ID: 30204526
    [No Abstract]   [Full Text] [Related]  

  • 10. Lidcombe Program translation to community clinics in Australia and England.
    O'Brian S; Hayhow R; Jones M; Packman A; Iverach L; Onslow M; Menzies R
    Int J Lang Commun Disord; 2023 Mar; 58(2):295-309. PubMed ID: 36114801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unscheduled telephone calls to measure percent syllables stuttered during clinical trials.
    Karimi H; O'Brian S; Onslow M; Jones M; Menzies R; Packman A
    J Speech Lang Hear Res; 2013 Oct; 56(5):1455-61. PubMed ID: 23785177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection from harm: the experience of adults after therapy with prolonged-speech.
    Cream A; Onslow M; Packman A; Llewellyn G
    Int J Lang Commun Disord; 2003; 38(4):379-95. PubMed ID: 14578053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II trial of the Westmead Program: syllable-timed speech treatment for pre-school children who stutter.
    Trajkovski N; Andrews C; Onslow M; O'Brian S; Packman A; Menzies R
    Int J Speech Lang Pathol; 2011 Dec; 13(6):500-9. PubMed ID: 22070727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connecting stuttering measurement and management: III. Accountable therapy.
    Cook F; Fry J
    Int J Lang Commun Disord; 2006; 41(4):379-94. PubMed ID: 16815807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-modelling as a relapse intervention following speech-restructuring treatment for stuttering.
    Cream A; O'Brian S; Onslow M; Packman A; Menzies R
    Int J Lang Commun Disord; 2009; 44(5):587-99. PubMed ID: 19925353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II clinical trial of self-imposed time-out treatment for stuttering in adults and adolescents.
    Hewat S; Onslow M; Packman A; O'Brian S
    Disabil Rehabil; 2006 Jan; 28(1):33-42. PubMed ID: 16393831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Webcam delivery of the Camperdown Program for adolescents who stutter: a phase I trial.
    Carey B; O'Brian S; Onslow M; Packman A; Menzies R
    Lang Speech Hear Serv Sch; 2012 Jul; 43(3):370-80. PubMed ID: 22232423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speech naturalness and prolonged-speech treatments for stuttering: further variables and data.
    Onslow M; Hayes B; Hutchins L; Newman D
    J Speech Hear Res; 1992 Apr; 35(2):274-82. PubMed ID: 1573867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating functional measures with treatment: a tactic for enhancing personally significant change in the treatment of adults and adolescents who stutter.
    Ingham RJ; Ingham JC; Bothe AK
    Am J Speech Lang Pathol; 2012 Aug; 21(3):264-77. PubMed ID: 22493023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Speech motor correlates of treatment-related changes in stuttering severity and speech naturalness.
    Tasko SM; McClean MD; Runyan CM
    J Commun Disord; 2007; 40(1):42-65. PubMed ID: 16765980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.